Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
‘Hard’ scientists should stop looking down their noses at social scientists, and instead share methods that could help them address pressing societal problems.
Negotiations over a sensitive scientific publication that could be misused by bioterrorists highlight trouble ahead unless appropriate guidelines are developed.
These days, it takes a brave laboratory to hitch its future to the construction of a brand-new particle accelerator — but Fermilab has elected to do just that.
A vote by the US House of Representatives to ease restrictions on embryonic stem-cell research marks an important turning point — whether President Bush vetoes the change or not.
This issue's focus on avian flu highlights progress and incoherence in the world's response to a potential human pandemic. But the threat is enormous, and some priorities are clear enough.
Despite the hype, there's no sign that the Congress will produce an energy bill worthy of the formidable energy-policy challenges faced by the United States.
Britain's research base is flourishing, and Tony Blair's last two governments can take much of the credit for it. But his third needs to focus on the troubled state of the universities.
The study of functioning groups of molecules is an important frontier of biology at reductionist and holistic levels. Central to the long-term goals of scientific research, it brings its own challenges of infrastructure and evaluation.